brentuximab,Dacarbazine,Doxorubicin Hydrochloride,Filgrastim,Nivolumab,Pegfilgrastim,Vinblastine Sulfate
seagen,amgen,Bms
['opdivo', 'lymphoma', 'adcetris', 'hodgkin', 'bristol']
compared with adcetris, bristol myers squibb s opdivo significantly reduced the risk of cancer progression or death by 52% in adults and children with newly diagnosed stage 3 or 4 classical hodgkin lymphoma, according to phase 3 data unveiled at the 2023 asco. 
a well educated drug dealer @Shanghai.♥biotech investor